|
Oct 9
|
Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigating Challenges and Opportunities ...
|
|
Oct 8
|
Liquidia Technologies (LQDA) Surges 11.2%: Is This an Indication of Further Gains?
|
|
Oct 7
|
Liquidia Shares Jump After US Supreme Court Rejects United Therapeutics' Appeal in Patent Dispute
|
|
Oct 7
|
United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent
|
|
Oct 2
|
Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)
|
|
Sep 30
|
Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting
|
|
Aug 28
|
Liquidia to Present at Upcoming Investor Conferences
|
|
Aug 26
|
Jim Cramer Says Liquidia Corporation (LQDA) Has Been Going ‘Down, Down, Down’
|
|
Jul 19
|
High Insider Ownership Marks These US Growth Companies For July 2024
|
|
Jun 10
|
Liquidia Insiders Placed Bullish Bets Worth US$3.00m
|
|
May 15
|
Liquidia Corp (LQDA) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...
|
|
May 15
|
Q1 2024 Liquidia Corp Earnings Call
|
|
May 14
|
Liquidia (NASDAQ:LQDA) shareholders have earned a 64% CAGR over the last three years
|
|
May 14
|
Down -11.26% in 4 Weeks, Here's Why You Should You Buy the Dip in Liquidia Technologies (LQDA)
|
|
May 13
|
Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update
|
|
May 10
|
Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD
|
|
May 7
|
Liquidia Corporation to Present at BofA Securities Health Care Conference 2024
|
|
May 7
|
Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024
|
|
Apr 26
|
Will Editas Medicine (EDIT) Report Negative Q1 Earnings? What You Should Know
|
|
Apr 25
|
Earnings Preview: Liquidia Technologies, Inc. (LQDA) Q1 Earnings Expected to Decline
|